{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioequivalence&page=17", "query": { "condition": "Bioequivalence", "page": 17 }, "page_size": 10 }, "pagination": { "page": 17, "page_size": 10, "total_count": 783, "total_pages": 79, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioequivalence&page=18&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioequivalence&page=16&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T08:39:14.719Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00840398", "title": "Buspirone Hydrochloride 30mg Tablets, Non-Fasting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "BUSPAR® 30 mg Tablet", "type": "DRUG" }, { "name": "Buspirone Hydrochloride 30 mg Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2001-12", "completion_date": "2001-12", "has_results": false, "last_update_posted_date": "2024-08-19", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00840398" }, { "nct_id": "NCT00833664", "title": "Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Terbinafine HCl 250mg tablets", "type": "DRUG" }, { "name": "Lamisil® 250 mg Tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2002-01", "completion_date": "2002-01", "has_results": true, "last_update_posted_date": "2023-05-30", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00833664" }, { "nct_id": "NCT00650000", "title": "Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Modafinil Tablets 200 mg", "type": "DRUG" }, { "name": "Provigil® Tablets 200 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2002-10", "completion_date": "2002-10", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00650000" }, { "nct_id": "NCT00649402", "title": "Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healhty" ], "interventions": [ { "name": "Amlodipine and Benazepril HCl Capsules 10 mg/20 mg", "type": "DRUG" }, { "name": "Lotrel® Capsules 10 mg/20 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2004-05", "completion_date": "2004-06", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00649402" }, { "nct_id": "NCT00650286", "title": "Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Modafinil Tablets 200 mg", "type": "DRUG" }, { "name": "Provigil® Tablets 200 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2002-09", "completion_date": "2002-10", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00650286" }, { "nct_id": "NCT00778024", "title": "Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "fluoxetine HCL 40 mg capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ranbaxy Laboratories Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2003-08", "completion_date": "2003-12", "has_results": false, "last_update_posted_date": "2009-12-15", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00778024" }, { "nct_id": "NCT02246920", "title": "Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "Flonase®", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1474, "start_date": "2014-03-01", "completion_date": "2014-07-14", "has_results": true, "last_update_posted_date": "2023-06-08", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02246920" }, { "nct_id": "NCT00865059", "title": "A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Gabapentin 800 mg Tablets, single dose", "type": "DRUG" }, { "name": "NEURONTIN® 800 mg Tablets, single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2001-02", "completion_date": "2001-03", "has_results": false, "last_update_posted_date": "2010-08-17", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00865059" }, { "nct_id": "NCT00899470", "title": "Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Co-administration of Saxagliptin and Metformin IR, Fasted", "type": "DRUG" }, { "name": "Saxagliptin/Metformin, Fasting", "type": "DRUG" }, { "name": "Co-administration of Saxagliptin and Metformin IR, Fed", "type": "DRUG" }, { "name": "Saxagliptin/Metformin, Fed", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "19 Years to 45 Years" }, "enrollment_count": 24, "start_date": "2009-06", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2015-06-01", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00899470" }, { "nct_id": "NCT03259958", "title": "A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Donepezil TDS", "type": "DRUG" }, { "name": "Aricept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Corium, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 86, "start_date": "2017-10-30", "completion_date": "2018-03-14", "has_results": false, "last_update_posted_date": "2018-08-01", "last_synced_at": "2026-10-24T08:39:14.719Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03259958" } ] }